ColdZyme Mouth & Throat Spray (Not Nasal Spray) - Cold Virus Treatment & Symptom Relief - Use at First Signs of a Cold - Menthol Flavour 20ml

Product Information

EUR-Lex. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745 (accessed on 20 March 2021).

While cloth coverings are fine for everyday use, the European Centre for Disease Prevention and Control says only surgical masks should be worn when you can't socially distance. Federal Agency for Medicines and Health Products (FAMHP) CE marking. [(accessed on 20 March 2021)]; Available online: https://www.famhp.be/en/human_use/health_products/medical_devices_access.... His parents commenced a twice daily treatment (morning and evening) of him with ColdZyme. The dose of the mouth spray was lower than the recommended dose of six times per day according to the instructions on the label. Further, the 15months of preventative use was outside the intended use range of ColdZyme; that is, not to be used for more than 30 consecutive days. Weekly symptoms (malaise, fever, earache, sore throat, rhinorrhea, gastrointestinal symptoms, dry cough, mucus cough, cold sores) were recorded using a two-graded scale (yes/no) in an infection diary. His guardians had recorded infection symptoms since he was diagnosed as having CVID 10years earlier, to follow the effect of the IgG treatment. Thus, historical data on self-reported infection frequency were available. In addition, a HRQL-related status such as days spent at home from school was also recorded. His IgG replacement treatment continued on a weekly basis and after 27weeks of ColdZyme treatment, measurement of his S-IgG showed a level of 7.63g/L. Veirusýkingar íöndunarfærum, einnig þekkt sem kvef eru algengasti smitsjúkdómur mannkynsins. Margar gerðir veira valda kvefi en algengastar eru rhinoveirur. 1 CZ-MD = Control group for number of episodes/person (No data on the proportions of persons per treatment group). Other parameters (e.g., claimed reduction of the CC episode by 3.5 days with CZ-MD versus controls) are not corroborated by the fact that less subjects in the control group felt need for rescue medication than on CZ-MD (38% vs 48%). No significant effects on training-related outcomes. Data on CC episodes were not or not consistently corrected for compliance versus baseline variables and different treatment periods.Burton, M.J.; Clarkson, J.E.; Goulao, B.; Glenny, A.M.; McBain, A.J.; Schilder, A.G.; Webster, K.E.; Worthington, H.V. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. Cochrane Database Syst. Rev. 2020, 9, CD013627. [ Google Scholar] [ CrossRef] [ PubMed] Direct mixing of CZ-MD formulation with virus. Reaction mixture was mixed with equal volume of “neutralizer” before dilution and culture with host cells in MEM in presence of TI: National Institute of Health, U.S. National Library of Medicine. Evaluation of ColdZyme ® on Experimentally Induced Common Cold. (COLDPREVII). Available online: https://clinicaltrials.gov/ct2/show/NCT02479750 (accessed on 20 March 2021).

Jamieson, M. EIS Help Athletes Manage Illness Over the Holiday Season. Available online: https://www.eis2win.co.uk/article/eis-help-athletes-manage-illness-over-the-holiday-season (accessed on 20 March 2021). Edwards, C.E.; Yount, B.L.; Graham, R.L.; Leist, S.R.; Hou, Y.J.; Dinnon 3rd, K.H.; Sims, A.C.; Swanstrom, J.; Gully, K.; Scobey, T.D.; et al. Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection. Proc. Natl. Acad. Sci. USA 2020, 117, 26915–26925. [ Google Scholar] [ CrossRef]

This case report emphasizes the possible importance of the interplay between viral and bacterial species in infections and by targeting the viral infection it might also be possible to prevent secondary bacterial infections. If you do not have cold symptoms but are at risk of catching a cold virus, e.g. if someone close to you has a cold, you can use ColdZyme for prevention. We evaluated such an oral spray, containing glycerol and the serine protease trypsin, available as MD under the brand name Viruprotect ® or ColdZyme ® (further abbreviated as CZ-MD). This spray is marketed as Viruprotect ® by Enzymatica ltd and its licensee-holder STADA throughout most European countries [ 6], while as ColdZyme ® (CZ-MD) by Boots ltd. in the United Kingdom (UK) [ 7].